Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Leiomyoma × Medroxyprogesterone Acetate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Endometrial Neoplasms 5 Endometrial Hyperplasia 2 Neoplasms 1 Menorrhagia 1 Leiomyoma 1

Interventions

relugolix 4 epigallocatechin gallate 2 Vitamin D 2 Vitamin B 6 2 Uterine Myomectomy 1 Tea 1 Sodium Chloride 1 Robotic Surgical Procedures 1 Methadone 1 Megestrol Acetate 1 Medroxyprogesterone Acetate 1 Letrozole 1 Hysterectomy 1 Bupivacaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06671548 2026-02-02

Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Qilu Pharmaceutical Co., Ltd.

Phase 3 Recruiting

Leiomyoma, Menorrhagia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡